Synopsis:
Sattva Engineering Construction won a Rs. 125.34 crore contract to design, build, and operate a 47 MLD water treatment plant in Surapet with 10-year O&M.
Known for its expertise in infrastructure and wastewater management solutions, the company has secured a significant order from the Chennai Metropolitan Water Supply and Sewerage Board. The project involves designing, building, and operating a 47 MLD water treatment plant in Surapet, providing long-term revenue visibility and boosting investor sentiment.
Sattva Engineering Construction Limited’s stock, with a market capitalisation of Rs. 182 crores, rose to Rs. 105.60, hitting a high of up to 4.97 percent (upper circuit) from its previous closing price of Rs. 100.60.
Order details
Sattva Engineering Construction Limited has received a contract from the Chennai Metropolitan Water Supply and Sewerage Board (CMWSSB) to design, build, operate, and transfer a 47 million liters per day (MLD) water treatment plant at Surapet. The project will be carried out under strict terms including ten years of operation and maintenance, adherence to tender guidelines, and no extra fee for technical changes, with all rules as per Tamil Nadu Tender Laws.
The contract duration is 21 months for construction of the water plant, followed by 10 years of operating and maintaining the facility. The total value of the order is Rs. 125.34 crore (including GST at 18%), which covers Rs. 74.75 crore for construction and Rs. 50.59 crore for ten years of operations and maintenance.
Also read: Railway stock jumps after securing ₹103 Cr worth of orders from domestic clients
Financial Highlights
The company reported a revenue of Rs. 93.65 crore in March 2025, up 21.7% YoY from Rs. 76.93 crore in March 2024. Over the last three years, revenue has grown at a modest CAGR of 2%, reflecting steady but limited top-line expansion.
Profit, however, increased sharply to Rs. 9.14 crore in March 2025 from Rs. 4.56 crore a year earlier, marking an 100% YoY increase. Furthermore, the company delivered a strong 3-year profit CAGR of 112% and maintained a healthy 3-year ROE CAGR of 20%. Its balance sheet remains moderately leveraged with a debt-to-equity ratio of 0.83.
Written By Fazal Ul Vahab C H
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
